Home › Funds › Almitas Capital LLC › ANTX

Almitas Capital LLC position in ANTX

AN2 THERAPEUTICS INC · Health Care

Almitas Capital LLC reported holding 1,469,129 shares of ANTX (AN2 THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$7.1M, representing 1.70% of its reported portfolio and ranking #12 among its reported holdings. Almitas Capital LLC has disclosed ANTX holdings in 7 of the last 7 reported quarters, going back to Q4 2024.

Latest position (Q2 2026)1.47M sh
Reported value held$7.11M
Portfolio Weight1.70%
First reportedQ4 2024
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Almitas Capital LLC's ANTX position evolved

Almitas Capital LLC first disclosed a stake in ANTX in Q4 2024 at 1,313,111 shares (US$1.8M). The position peaked in Q2 2026 at 1,469,129 shares, worth US$7.1M. Across 7 filings, Almitas Capital LLC increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 3 time(s). The most recent filing (Q2 2026) shows 1,469,129 shares valued at US$7.1M — a reduction of -10,000 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q4 2024 1.31M $1.81M New
Q1 2025 1.31M $1.79M Hold
Q2 2025 1.43M $1.51M Add
Q3 2025 1.43M $1.81M Hold
Q4 2025 1.48M $1.69M Add
Q1 2026 1.48M $5.06M Hold
Q2 2026 1.47M $7.11M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ANTX and 13F data

ANTX (AN2 THERAPEUTICS INC) is a Health Care company. 45 other funds we track also report a position in ANTX — the largest reported positions include Vivo Capital, LLC (US$15.3M), Commodore Capital LP (US$14.2M), Spruce Street Capital LP (US$8.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ANTX

All ANTX fund holders →

FAQ

How long has Almitas Capital LLC held ANTX?

Almitas Capital LLC has disclosed ANTX holdings in 7 of the last 7 reported quarters, going back to Q4 2024.

What is Almitas Capital LLC's current position in ANTX?

As of Q2 2026, Almitas Capital LLC holds 1.47M shares of ANTX (AN2 THERAPEUTICS INC), valued at $7.11M, representing 1.70% of its reported portfolio and ranking #12.

Has Almitas Capital LLC been buying or selling ANTX?

In the latest 13F filing (Q2 2026), Almitas Capital LLC reduced its position in ANTX. The position peaked in Q2 2026 at 1.47M shares.

Which other funds hold ANTX?

Other major institutional holders of ANTX include Vivo Capital, LLC, Commodore Capital LP, Spruce Street Capital LP, among 45 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.